1. Home
  2. MLAB vs KMDA Comparison

MLAB vs KMDA Comparison

Compare MLAB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • KMDA
  • Stock Information
  • Founded
  • MLAB 1982
  • KMDA 1990
  • Country
  • MLAB United States
  • KMDA Israel
  • Employees
  • MLAB N/A
  • KMDA N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLAB Industrials
  • KMDA Health Care
  • Exchange
  • MLAB Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • MLAB 341.1M
  • KMDA 392.2M
  • IPO Year
  • MLAB N/A
  • KMDA N/A
  • Fundamental
  • Price
  • MLAB $68.98
  • KMDA $6.63
  • Analyst Decision
  • MLAB Buy
  • KMDA Strong Buy
  • Analyst Count
  • MLAB 2
  • KMDA 2
  • Target Price
  • MLAB $113.50
  • KMDA $13.00
  • AVG Volume (30 Days)
  • MLAB 195.2K
  • KMDA 52.4K
  • Earning Date
  • MLAB 11-06-2025
  • KMDA 11-12-2025
  • Dividend Yield
  • MLAB 0.89%
  • KMDA 3.01%
  • EPS Growth
  • MLAB N/A
  • KMDA 27.97
  • EPS
  • MLAB N/A
  • KMDA 0.32
  • Revenue
  • MLAB $242,351,000.00
  • KMDA $169,517,000.00
  • Revenue This Year
  • MLAB $5.38
  • KMDA $14.49
  • Revenue Next Year
  • MLAB $5.25
  • KMDA $10.12
  • P/E Ratio
  • MLAB N/A
  • KMDA $20.86
  • Revenue Growth
  • MLAB 8.33
  • KMDA 9.67
  • 52 Week Low
  • MLAB $55.45
  • KMDA $5.18
  • 52 Week High
  • MLAB $155.12
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 48.73
  • KMDA 38.27
  • Support Level
  • MLAB $63.48
  • KMDA $6.76
  • Resistance Level
  • MLAB $75.10
  • KMDA $6.89
  • Average True Range (ATR)
  • MLAB 4.09
  • KMDA 0.14
  • MACD
  • MLAB 0.81
  • KMDA -0.01
  • Stochastic Oscillator
  • MLAB 42.97
  • KMDA 24.68

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: